Literature DB >> 32581390

Assessment of retinal neurodegeneration with spectral-domain optical coherence tomography: a systematic review and meta-analysis.

Ziqi Tang1, Ming Yan Chan1, Wai Yin Leung1, Ho Yeung Wong1, Ching Man Ng1, Victor T T Chan1, Raymond Wong1,2, Jerry Lok1,2, Simon Szeto1,2, Jason C K Chan1,2, Clement C Tham1,2, Tien Y Wong3, Carol Y Cheung4.   

Abstract

OBJECTIVES: To comprehensively assess diabetic retinopathy neurodegeneration (DRN) as quantified by retinal neuronal and axonal layers measured with spectral-domain optical coherence tomography (SD-OCT) in subjects with diabetes mellitus (DM).
METHODS: Articles on the topic of examining macular ganglion cell-inner plexiform layer (m-GCIPL), macular retinal nerve fibre layer (m-RNFL), macular ganglion cell complex (m-GCC), and peripapillary RNFL (p-RNFL) measured with SD-OCT in DM subjects without DR (NDR) or with non-proliferative DR (NPDR) were searched in PubMed and Embase up to November 31, 2019. Standardized mean difference (SMD) as effect size were pooled using random-effects model.
RESULTS: Thirty-six studies searched from online databases and the CUHK DM cohort were included in the meta-analysis. In the comparison between NDR and control, macular measures including mean m-GCIPL (SMD = -0.26, p = 0.003), m-RNFL (SMD = -0.26, p = 0.046), and m-GCC (SMD = -0.28; p = 0.009) were significantly thinner in the NDR group. In the comparison between NPDR and NDR, only mean p-RNFL was significantly thinner in the NPDR group (SMD = -0.27; p = 0.03), but not other macular measures.
CONCLUSIONS: Thinning of retinal neuronal and axonal layers at macula as measured by SD-OCT are presented in eyes with NDR, supporting DRN may be the early pathogenesis in the DM patients without the presence of clinical signs of DR. In the future, these SD-OCT measures may be used as surrogates of DRN to stratify DM patients with a high risk of DR, and may be used as a therapeutic target if neuroprotection treatment for DR is available.

Entities:  

Mesh:

Year:  2020        PMID: 32581390      PMCID: PMC8182828          DOI: 10.1038/s41433-020-1020-z

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  61 in total

Review 1.  Diabetic retinopathy.

Authors:  David A Antonetti; Ronald Klein; Thomas W Gardner
Journal:  N Engl J Med       Date:  2012-03-29       Impact factor: 91.245

2.  Neuroretinal alterations in the early stages of diabetic retinopathy in patients with type 2 diabetes mellitus.

Authors:  P Carpineto; L Toto; R Aloia; V Ciciarelli; E Borrelli; E Vitacolonna; M Di Nicola; L Di Antonio; R Mastropasqua
Journal:  Eye (Lond)       Date:  2016-02-12       Impact factor: 3.775

Review 3.  Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence.

Authors:  Rafael Simó; Cristina Hernández
Journal:  Prog Retin Eye Res       Date:  2015-04-30       Impact factor: 21.198

4.  Neurodegeneration in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography.

Authors:  Jay Chhablani; Apoorva Sharma; Abhilash Goud; Hari Kumar Peguda; Harsha L Rao; Viquar Unnisa Begum; Giulio Barteselli
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

Review 5.  Diabetic retinopathy.

Authors:  Ning Cheung; Paul Mitchell; Tien Yin Wong
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321

6.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

7.  Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration.

Authors:  Esther Carrasco; Cristina Hernández; Adela Miralles; Pere Huguet; Jaume Farrés; Rafael Simó
Journal:  Diabetes Care       Date:  2007-08-17       Impact factor: 19.112

8.  Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.

Authors:  Elliott H Sohn; Hille W van Dijk; Chunhua Jiao; Pauline H B Kok; Woojin Jeong; Nazli Demirkaya; Allison Garmager; Ferdinand Wit; Murat Kucukevcilioglu; Mirjam E J van Velthoven; J Hans DeVries; Robert F Mullins; Markus H Kuehn; Reinier Otto Schlingemann; Milan Sonka; Frank D Verbraak; Michael David Abràmoff
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

Review 9.  Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives.

Authors:  Rafael Simó; Cristina Hernández
Journal:  Trends Endocrinol Metab       Date:  2013-11-01       Impact factor: 12.015

Review 10.  Global prevalence and major risk factors of diabetic retinopathy.

Authors:  Joanne W Y Yau; Sophie L Rogers; Ryo Kawasaki; Ecosse L Lamoureux; Jonathan W Kowalski; Toke Bek; Shih-Jen Chen; Jacqueline M Dekker; Astrid Fletcher; Jakob Grauslund; Steven Haffner; Richard F Hamman; M Kamran Ikram; Takamasa Kayama; Barbara E K Klein; Ronald Klein; Sannapaneni Krishnaiah; Korapat Mayurasakorn; Joseph P O'Hare; Trevor J Orchard; Massimo Porta; Mohan Rema; Monique S Roy; Tarun Sharma; Jonathan Shaw; Hugh Taylor; James M Tielsch; Rohit Varma; Jie Jin Wang; Ningli Wang; Sheila West; Liang Xu; Miho Yasuda; Xinzhi Zhang; Paul Mitchell; Tien Y Wong
Journal:  Diabetes Care       Date:  2012-02-01       Impact factor: 19.112

View more
  3 in total

Review 1.  The cross-sectional and longitudinal relationship of diabetic retinopathy to cognitive impairment: a systematic review and meta-analysis.

Authors:  Robert N F Chan; Ziqi Tang; Victor T T Chan; Raymond N C Chan; Esther T W Cheng; Natalie C Y Ng; Carol Y Cheung
Journal:  Eye (Lond)       Date:  2022-05-02       Impact factor: 3.775

Review 2.  Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review.

Authors:  Francesco Oddone; Luca Rossetti; Mariacristina Parravano; Diego Sbardella; Massimo Coletta; Lucia Ziccardi; Gloria Roberti; Carmela Carnevale; Dario Romano; Gianluca Manni; Vincenzo Parisi
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-20

3.  Detecting retinal neurodegeneration in people with diabetes: Findings from the UK Biobank.

Authors:  Roomasa Channa; Kyungmoo Lee; Kristen A Staggers; Nitish Mehta; Sidra Zafar; Jie Gao; Benjamin J Frankfort; Sharon Y L Chua; Anthony P Khawaja; Paul J Foster; Praveen J Patel; Charles G Minard; Chris Amos; Michael D Abramoff
Journal:  PLoS One       Date:  2021-09-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.